Skip to NavigationSkip to content

News

0
Bayer is set to acquire UK-based biotech KaNDy Therapeutics, assimilating the firm’s women’s healthcare development portfolio in a newly announced...
0
Roche has voiced its disappointment after its investigational therapy etrolizumab showed “mixed results” as a treatment for moderately to severely...
0
The treatment is already available on an emergency basis for people suffering with severe symptoms from coronavirus. It has not received general...
0
People with type 1 diabetes could see their lives extended by the arthritis drug Abatacept, new study finds.

Features

CAR T cell therapy, while a revolutionary and life-saving technology, is extremely expensive and is not guaranteed to work, meaning that American...